https://wiki.tiffa.net/w/index.php?action=history&feed=atom&title=Translations%3AAnti-obesity_medication%2F22%2Fja 2026-08-22T10:58:44Z Revision history for this page on the wiki MediaWiki 1.43.0 https://wiki.tiffa.net/w/index.php?title=Translations:Anti-obesity_medication/22/ja&diff=125319&oldid=prev 2024-03-07T09:45:22Z

<p>Created page with &quot;|- |<a href="/wiki/Metformin/ja" title="Metformin/ja">メトホルミン</a> |グルコファージ |不明 |2型糖尿病治療薬として承認されている |5.6% |- |<a href="/w/index.php?title=Cagrilintide/ja&amp;action=edit&amp;redlink=1" class="new" title="Cagrilintide/ja (page does not exist)">Cagrilintide/ja</a> | |<a href="/w/index.php?title=Dual_amylin_and_calcitonin_receptor_agonist/ja&amp;action=edit&amp;redlink=1" class="new" title="Dual amylin and calcitonin receptor agonist/ja (page does not exist)">Dual amylin and calcitonin receptor agonist/ja</a> (DACRA) |未承認 |7.8% |- |<a href="/w/index.php?title=Cagrilintide/semaglutide/ja&amp;action=edit&amp;redlink=1" class="new" title="Cagrilintide/semaglutide/ja (page does not exist)">Cagrilintide/semaglutide/ja</a> |カグリセマ |DACRA/GLP-1作動薬配合剤 |未承認 |32週後に15.4% |}&quot;</p> <p><b>New page</b></p><div>|-<br /> |[[Metformin/ja]]<br /> |グルコファージ<br /> |不明<br /> |2型糖尿病治療薬として承認されている<br /> |5.6%<br /> |-<br /> |[[Cagrilintide/ja]]<br /> |<br /> |[[Dual amylin and calcitonin receptor agonist/ja]] (DACRA)<br /> |未承認<br /> |7.8%<br /> |-<br /> |[[Cagrilintide/semaglutide/ja]]<br /> |カグリセマ<br /> |DACRA/GLP-1作動薬配合剤<br /> |未承認<br /> |32週後に15.4%<br /> |}</div>

Fire